{"id":"https://openalex.org/A5014643231","orcid":"https://orcid.org/0000-0001-5860-8762","observed_orcids":["https://orcid.org/0000-0001-5860-8762"],"display_name":"Emma L. Jenkins","raw_author_names":["Emma Jenkins","Emma L. Jenkins","Emma-Louise Jenkins","Jenkins, Emma"],"full_name":"Emma L. Jenkins","works_count":18,"cited_by_count":490,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":6,"i10_index":6},"ids":{"openalex":"https://openalex.org/A5014643231","orcid":"https://orcid.org/0000-0001-5860-8762","observed_orcids":["https://orcid.org/0000-0001-5860-8762"]},"affiliations":[{"institution":{"id":"https://openalex.org/I1288882113","ror":"https://ror.org/00dvg7y05","display_name":"Boston Children's Hospital","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},"years":[2022]},{"institution":{"id":"https://openalex.org/I2802901496","ror":"https://ror.org/031p4kj21","display_name":"Bristol Royal Infirmary","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]},"years":[2010]},{"institution":{"id":"https://openalex.org/I36234482","ror":"https://ror.org/0524sp257","display_name":"University of Bristol","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]},"years":[2015,2010,2008]},{"institution":{"id":"https://openalex.org/I4210150756","ror":"https://ror.org/043cec594","display_name":"AstraZeneca (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]},"years":[2016,2013]}],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":5,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","count":5,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","count":4,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12835","display_name":"FOXO transcription factor regulation","value":7.79e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","value":5.52e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":5.05e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","value":3.21e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","value":2.5e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","score":0.7279406785964966},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.6229181885719299},{"id":"104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","score":0.5380669832229614},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.48567330837249756},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.3513006567955017}],"counts_by_year":[{"year":2008,"works_count":2,"oa_works_count":2,"cited_by_count":0},{"year":2010,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":31},{"year":2013,"works_count":2,"oa_works_count":0,"cited_by_count":25},{"year":2014,"works_count":1,"oa_works_count":0,"cited_by_count":32},{"year":2015,"works_count":2,"oa_works_count":1,"cited_by_count":25},{"year":2016,"works_count":1,"oa_works_count":1,"cited_by_count":33},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":45},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":23},{"year":2019,"works_count":4,"oa_works_count":0,"cited_by_count":25},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":39},{"year":2021,"works_count":1,"oa_works_count":0,"cited_by_count":44},{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":20},{"year":2023,"works_count":2,"oa_works_count":2,"cited_by_count":28},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":29},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":31},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":6}],"display_name_alternatives":["Emma Jenkins","Emma L. Jenkins","Emma-Louise Jenkins","Jenkins, Emma"],"block_key":"e jenkins","works_api_url":"https://api.openalex.org/works?filter=author.id:A5014643231","updated_date":"2026-11-09T14:06:01","created_date":"2016-06-24T00:00:00"}